Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up.
作者信息
Dreyling Martin, Goy Andre, Hess Georg, Kahl Brad S, Hernández-Rivas José-Ángel, Schuier Natasha, Qi Keqin, Deshpande Sanjay, Zhu Angeline, Parisi Lori, Wang Michael L
机构信息
Department of Medicine III, University Hospital, Ludwig Maximilians University, Munich, Germany.
Department of Hematology & Oncology, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, USA.
出版信息
Hemasphere. 2022 Apr 13;6(5):e712. doi: 10.1097/HS9.0000000000000712. eCollection 2022 May.
Abstract
摘要
Zotero 插件